Clinical trial

Effect of Nasal Continuous Positive Airway Pressure (CPAP) Blood Pressure and…

NCT00300872 · Chinese University of Hong Kong, Other · Completed

Key facts

NCT number NCT00300872
Title Effect of Nasal Continuous Positive Airway Pressure (CPAP) Blood Pressure and Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome
Official title A Randomized, Placebo-controlled Study of the Medium-term Effect of Nasal CPAP on 24 Hour Blood Pressure and Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome
Lead sponsor Chinese University of Hong Kong, Other
Status Completed
Study type Interventional
Conditions Obstructive Sleep Apnea
Intervention type Device
Interventions Continuous positive airway pressure (CPAP), Sham Continuous positive airway pressure (CPAP)
Enrollment 140
Start date Jan 1, 2005
Primary completion Aug 6, 2019
Completion Aug 6, 2019
First posted Mar 10, 2006
Last update posted Jan 27, 2021
Countries Hong Kong

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies